MBX Biosciences (MBX)
64.25
-2.14 (3.22%)
Upcoming Events
Latest Headlines
Form 8-K MBX Biosciences, Inc. For: Aug 27
August 27, 2026 8:35 AM - SEC Filing
MBX Biosciences doses first patient in Phase 3 hypoparathyroidism trial
August 27, 2026 8:01 AM - StreetInsider
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
August 27, 2026 8:00 AM - Globe NewsWire
JPMorgan Reinstates MBX Biosciences Inc (MBX) at Overweight
August 21, 2026 3:27 AM - StreetInsider
Form 144 MBX Biosciences, Inc. Filed by: Hawryluk P. Kent
August 17, 2026 3:41 PM - SEC Filing
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: Deep Track Capital, LP
August 14, 2026 8:28 AM - SEC Filing
Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
August 10, 2026 5:36 PM - SEC Filing
Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
August 10, 2026 4:44 PM - SEC Filing
MBX Biosciences Inc (MBX) PT Raised to $88 at Truist Securities
August 10, 2026 7:22 AM - StreetInsider
MBX Biosciences Inc (MBX) PT Raised to $88 at Barclays
August 10, 2026 4:22 AM - StreetInsider
MBX (MBX) Reports Q2 Loss of $0.78
August 6, 2026 8:09 AM - StreetInsider
Form 10-Q MBX Biosciences, Inc. For: Jun 30
August 6, 2026 8:07 AM - SEC Filing
Form 8-K MBX Biosciences, Inc. For: Aug 06
August 6, 2026 8:04 AM - SEC Filing
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 6, 2026 8:01 AM - Globe NewsWire
Form 4 MBX Biosciences, Inc. For: Aug 04 Filed by: Azoulay Salomon
August 5, 2026 4:57 PM - SEC Filing
Form 144 MBX Biosciences, Inc. Filed by: Hawryluk P. Kent
August 4, 2026 4:44 PM - SEC Filing
Form 144 MBX Biosciences, Inc. Filed by: Azoulay Salomon
August 4, 2026 4:42 PM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Aug 03 Filed by: Smither John W
August 4, 2026 8:51 AM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Aug 03 Filed by: Hoerter Steven L.
August 4, 2026 8:51 AM - SEC Filing
Form SCHEDULE 13G MBX Biosciences, Inc. Filed by: BlackRock, Inc.
July 29, 2026 3:21 PM - SEC Filing
MBX Biosciences Inc (MBX) PT Raised to $91 at Mizuho
July 29, 2026 6:45 AM - StreetInsider
Attovia Therapeutics names John Smither to board of directors
July 15, 2026 8:30 AM - StreetInsider
Attovia Therapeutics Appoints John W. Smither to Board of Directors
July 15, 2026 8:30 AM - Globe NewsWire
Form 8-K MBX Biosciences, Inc. For: Jul 09
July 13, 2026 4:46 PM - SEC Filing
MBX Biosciences names new CEO and CFO amid leadership shift
July 13, 2026 4:15 PM - StreetInsider
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
July 13, 2026 4:15 PM - Globe NewsWire
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
July 8, 2026 12:59 PM - SEC Filing
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: FMR LLC
July 8, 2026 10:12 AM - SEC Filing
Form SCHEDULE 13G MBX Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
June 24, 2026 4:06 PM - SEC Filing
Form 8-K MBX Biosciences, Inc. For: Jun 12
June 12, 2026 7:06 AM - SEC Filing
MBX Biosciences reports sustained one-year data for weekly drug trial
June 12, 2026 7:01 AM - StreetInsider
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
June 12, 2026 7:00 AM - Globe NewsWire
Form 144 MBX Biosciences, Inc. Filed by: Bartram Richard
June 10, 2026 12:41 PM - SEC Filing
Form 144 MBX Biosciences, Inc. Filed by: Bartram Richard
June 9, 2026 4:38 PM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Mathers Edward T
June 5, 2026 2:36 PM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Pescovitz Ora H.
June 5, 2026 7:59 AM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Heron Patrick J
June 5, 2026 7:59 AM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Stelzer Laurie
June 5, 2026 7:58 AM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Hoerter Steven L.
June 5, 2026 7:57 AM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Ryder Steven
June 5, 2026 7:54 AM - SEC Filing
Form 4 MBX Biosciences, Inc. For: Jun 04 Filed by: Aynechi Tiba
June 5, 2026 7:54 AM - SEC Filing
Form 8-K MBX Biosciences, Inc. For: Jun 04
June 5, 2026 7:53 AM - SEC Filing
MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026
June 1, 2026 8:01 AM - Globe NewsWire
Full Article List
